Oligonucleotides Targeting Telomeres and Telomerase in Cancer

Area of Science:

• Oncology
• Molecular Biology
• Biochemistry

Background:

• Telomeres and telomerase are crucial for cancer cell immortality.
• Dysregulation of telomere maintenance is a hallmark of cancer.
• Targeting telomeres and telomerase offers a promising strategy for anticancer drug development.

Purpose of the Study:

• To provide a comprehensive review of current oligonucleotide-based anticancer therapies targeting telomeres and telomerase.
• To discuss the mechanisms of action for these novel therapeutics.
• To highlight potential challenges and future directions for oligonucleotide therapy in a clinical setting.

Main Methods:

• Review of existing literature on oligonucleotide-based therapies targeting telomeres and telomerase.
• Analysis of studies investigating telomerase inhibitors, G-quadruplex ligands, and telomere-specific oligonucleotides.
• Examination of the role of microRNAs (miRNAs) in telomerase regulation and their therapeutic potential.

Main Results:

• Several oligonucleotide-based therapies, including GRN163L and T-oligos, have demonstrated significant anticancer activity.
• These agents induce potent DNA damage responses in cancer cells.
• MicroRNAs are implicated in regulating telomerase activity and represent potential therapeutic targets.

Conclusions:

• Oligonucleotide-based therapies targeting telomeres and telomerase are a developing area in cancer treatment.
• GRN163L and T-oligos show promise by inducing DNA damage responses.
• Targeting telomerase through oligonucleotides and miRNAs offers novel therapeutic avenues for cancer.